Aker BioMarine AS (AKBM.OL)

NOK 67.5

(-0.3%)

Market Cap (In NOK)

5.91 Billion

Revenue (In NOK)

335.3 Million

Net Income (In NOK)

-9 Million

Avg. Volume

110.07 Thousand

Currency
NOK
Country
Consumer Defensive
Open
-
Prev. Close
-
Day Range
-
Year Range
42.15-109.8
PE
-
EPS
-
Beta Value
0.837
ISIN
NO0010886625
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Consumer Defensive
Industry
Packaged Foods
CEO
Mr. Matts Johansen
Employee Count
-
Website
https://www.akerbiomarine.com
Ipo Date
2020-07-06
Details
Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates through two segments, Ingredients and Brands. It provides Superba, a krill-based ingredients for nutraceutical, including phospholipid complex of choline, omega-3s, and antioxidant astaxanthin; QRILL Aqua, a krill-based ingredients for aquaculture; and QRILL Pet, a krill-based ingredients animal feed application. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste and re-use materials. The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.

More Stocks